Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dermatologic therapy with immunosuppressive agents.

R I Rudolph, J J Leyden

    Postgraduate Medicine
    |August 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Development of an atrophic acne scar risk assessment tool.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2017
    Same author

    4-Hexyl-1,3-phenylenediol, a nuclear factor-κB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial.

    The British journal of dermatology·2015
    Same author

    Skin surface microflora of the saddle-back tamarin monkey,Saguinus fuscicollis.

    Journal of chemical ecology·2013
    Same author

    Analysis of characteristic odors from human male axillae.

    Journal of chemical ecology·2013
    Same author

    An investigation of human apocrine gland secretion for axillary odor precursors.

    Journal of chemical ecology·2013
    Same author

    Analysis of characteristic human female axillary odors: Qualitative comparison to males.

    Journal of chemical ecology·2013
    Same journal

    CV risk: if you aren't testing ACR, you aren't seeing the full picture.

    Postgraduate medicine·2026
    Same journal

    Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

    Postgraduate medicine·2026
    Same journal

    Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

    Postgraduate medicine·2026
    Same journal

    Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

    Postgraduate medicine·2026
    Same journal

    The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

    Postgraduate medicine·2026
    Same journal

    Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

    Postgraduate medicine·2026
    See all related articles

    Powerful immunosuppressive agents like methotrexate are effective for severe skin diseases. These drugs reduce the need for steroids, thereby lowering serious side effects from long-term steroid use.

    Area of Science:

    • Dermatology
    • Immunosuppression Therapy

    Background:

    • Serious skin diseases often require potent treatments.
    • Prolonged corticosteroid therapy can lead to significant adverse effects.

    Purpose of the Study:

    • To evaluate the efficacy of immunosuppressive agents in treating severe dermatological conditions.
    • To assess the potential of these agents to reduce corticosteroid dependency and associated side effects.

    Main Methods:

    • Review of studies utilizing immunosuppressive agents (methotrexate, cyclophosphamide, azathioprine) for severe skin diseases.
    • Analysis of treatment outcomes, focusing on disease control and steroid dosage reduction.

    Main Results:

    • Immunosuppressive agents demonstrate significant efficacy in managing severe skin diseases.

    Related Experiment Videos

  • Concurrent use of immunosuppressants allows for a notable decrease in required corticosteroid dosage.
  • Reduced steroid dosage correlates with a lower incidence of serious side effects.

    • Conclusions:

    • Immunosuppressive therapies represent a valuable advancement in treating severe skin conditions.
    • These agents offer a viable strategy to mitigate the risks associated with long-term corticosteroid use.